|
Market Closed -
Nasdaq
23:00:00 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 21.74 USD | +1.87% |
|
+8.81% | -18.82% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
AMPH 21.74 $
+1.87%
8.93M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| AMPH | 21.74USD | +1.87% | 8.93M $ | |
CBOE
| AMPH | 21.72USD | +1.71% | 293K $ | |
Tradegate
| 29A | 18.60EUR | +0.79% | 465.12 € | |
Deutsche Boerse AG
| 29A | 17.90EUR | +2.32% | 0 € | |
Börse Stuttgart
| 29A | 18.52EUR | +1.04% | 0 € | |
Boerse Muenchen
| 29A | 18.55EUR | +0.35% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 21.88 | 27.97 | 21.88 |
| Spread/Res. | -0.64% | -22.27% | -0.64% |
| Spread/Supp. | +8.81% | +28.87% | +28.87% |
| Support | 19.98 | 16.87 | 16.87 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMPH Stock
- Charts Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

















